Wilmington, Delaware, United States, Aug. 28, 2023 (GLOBE NEWSWIRE) — The global cell analysis market is projected to flourish at a CAGR of 9.2% from 2023 to 2031. As per the report published by TMR, a valuation of US$ 42.4 billion is anticipated for the market in 2031. As of 2023, the market for cell analysis is expected to close at US$ 20.7 billion.
Increasing advances in technology and growing innovations in microscopy, flow cytometry, high-throughput screening, and automated cell analysis platforms have increased the efficiency and accuracy of cell analysis processes.
The increasing incidence of chronic diseases like diabetes, cardiovascular diseases, and neurological disorders and growing demand for cell analysis for studying cancer cells, understanding tumour microenvironments, and investigating immune responses for the development of immunotherapies, offer opportunity for market growth.
Emergence of new treatments, advancements in medical devices and increased trend of personalized medicine has driven the need for precise cell analysis techniques to understand individual patient responses to treatments and therapies contribute to the market expansion.
For more insights into the Market, Request a Sample of this Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=12221
“Connect with our team of research specialists and unlock the optimal solution for driving your business growth”
Key Takeaways from the Market Study
- As of 2022, the cell analysis market was valued at US$ 19.0 billion
- Based on technology, the flow cytometry segment is anticipated to dominate the industry during the forecast period,
- In terms of end-user, the biotechnology & pharmaceutical companies segment is projected to account for the largest global cell analysis market share from 2023 to 2031.
- Based on therapeutic area, the oncology & immune-oncology segment dominated the market during the forecast period.
Cell Analysis Market: Key Trends and Opportunistic Frontiers
- Increasing research activities and investments in healthcare infrastructure in emerging economies contribute to the growth of the cell analysis market.
- Increasing technological integration as new technologies are integrated with existing ones to create more powerful and accurate tools for researchers and healthcare professionals.
- The market players are focusing on developing efficient and affordable personalized medicines using cell analysis in order to increase market share and presence.
For In-depth Competitive Analysis, Buy Now: https://www.transparencymarketresearch.com/checkout.php?rep_id=12221<ype=S
Coffee Servers Market– Regional Analysis
- North America is anticipated to hold the largest cell analysis market share during the forecast period owing to the strong presence of research, biotechnology, and pharmaceutical industries, driving demand for advanced cell analysis technologies in the region. The increasing government funding for life sciences research and biotechnology contributes to the growth of the cell analysis market in the region.
- Asia Pacific is expected to account for a significant market share in the cell analysis market. Increasing investment in biotechnology and life sciences research, led to increased demand for cell analysis in the region. The growing healthcare expenditure, increased population and growing focus on personalized medicine drives the demand for precise cell analysis solutions.
Competitive Landscape
The global cell analysis market is fragmented, with the presence of a small number of leading players. The leading players in the market are investing in new product development, mergers, and acquisitions to gain a competitive edge. Transparency Market Research has profiled the following players in its global cell analysis market report:
- In February 2023, Ultima Genomics, Inc. partnered with 10x Genomics to integrate the use of 10x Genomics Chromium Single Cell Gene Expression offerings with Ultima’s sequencing systems
- In July 2023 – Thermo Fisher Scientific Inc. announced that it has completed the acquisition of CorEvitas, LLC a leading provider of regulatory-grade, real-world evidence for approved medical treatments and therapies, from Audax Private Equity.
Request for Customization and Redefine Expectations: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=12221
Cell Analysis Market – Key Segments
End-user
- Biotechnology & Pharmaceutical Companies
- Therapeutic Area
- Oncology & Immune-oncology
- Small Molecules
- Protein-based Therapeutics
- Cell Therapy
- Nucleic Acid-based Drugs
- Cardiovascular & Metabolic Diseases
- Small Molecules
- Protein-based Therapeutics
- Cell Therapy
- Nucleic Acid-based Drugs
- Immunology
- Small Molecules
- Protein-based Therapeutics
- Cell Therapy
- Nucleic Acid-based Drugs
- Rare Diseases
- Small Molecules
- Protein-based Therapeutics
- Cell Therapy
- Nucleic Acid-based Drugs
- Neurological Diseases
- Small Molecules
- Protein-based Therapeutics
- Cell Therapy
- Nucleic Acid-based Drugs
- Others
- Small Molecules
- Protein-based Therapeutics
- Cell Therapy
- Nucleic Acid-based Drugs
- Technology
- Flow Cytometry
- Image-based Cytometry/Microscopy
- Biochemical Assays
- Mass Spectrometry
- Workplace
- Target Identification
- Hit Generation & Lead Identification
- Lead Optimization
- In Vitro Preclinical Studies
- In Vivo Preclinical Studies
- Clinical Studies
- Academia
- Cosmetic Industry
- Contract Research Organizations
- Contract Development & Manufacturing Organizations
Region
- U.S.
- Europe
- China
- Rest of the World
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
